IFNAR1 and neoplasm: Though both diminished and hyperactive IFN1 signaling promoted TNBC metastasis, suppression of EV release using reserpine delayed tumor growth and prevented loss of IFNAR1 in stromal cells even in the presence of paclitaxel.